Stacy Stein, MD, and co-investigators, research omalizumab to treat oxaliplatin hypersensitivity reactions for patients with gastrointestinal cancers.
Stacey Stein, MD
Advertisement
Articles by Stacey Stein, MD
Advertisement
Latest Updated Articles
A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity ReactionPublished: July 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
4
What Were The Most Impactful GU Oncology Data From ESMO 2025?
5
